Introduction
============

Malaria is the most important human parasitic disease, causing an estimated 500 million cases and more than 1 million deaths annually. *Plasmodium falciparum* is responsible for the most serious form of the disease with a significant mortality rate.

Objective
=========

To characterize severe *Plasmodium falciparum* malaria patterns in patients admitted to an Angolan general ICU.

Methods
=======

A retrospective study based on medical records of adult patients with severe *Plasmodium falciparum* malaria admitted between January 2006 and December 2008 at an Angolan University-affiliated teaching hospital. We collected data on demographics, malaria-related immunity status, clinical presentation, WHO malaria severity criteria, laboratory findings and outcome. Continuous data were analyzed with Students t-test. A *P* of less than 0.05 was regarded to be significant.

Results
=======

Out of 114 patients admitted with diagnosis of malaria, we enrolled 56 patients. Forty-four (79%) were males. The mean age was 43.0±12.9. Twenty-eight (50%) were nonimmune and only two were adherent to chemoprophylaxis, but reported taking it incorrectly. Fifty-two percent were admitted during the second trimester. The mean APACHE II was 15.4±8.7 with a mean predicted dead rate of 25.9%. The mean SOFA on admission was 7.6±3.6. Fever (82%) followed by headache (41%) and gastrointestinal symptoms (36%) were the most common symptoms on admission and jaundice (61 %) the most common sign. The mean duration of symptoms prior to presentation at the ED was 6.1 ±4.3 days. Malaria diagnosis was confirmed within 24 hours of admission to our hospital In all the cases. Twelve patients presented 2 or more WHO severity major criteria. Forty-one patients were treated with quinine and twelve with artemether. Nineteen patients (34%) required ventilatory support, twenty (36%) intermittent hemodialysis and twelve (21%) vasopressor support. The mean ICU length of stay was 5.5±3.8 days. The 2-day mortality rate and total ICU mortality rate recorded was 10.7% and 37.5%, respectively.

###### 

Characteristics of survival and nonsurvival groups

                                                   Survival (n=35)   Non-survival (n=21)   p
  ------------------------------------------------ ----------------- --------------------- ----------
  Age, Mean ± SD                                   43.7 ± 12.5       42.0 ± 14.0           0.66
  APACHE 11, Mean ± SD                             12.1 ± 6.2        21.0 ± 9.4            \<0.0001
  SOFA on admission (total), Mean ± SD             6.5 ± 3.3         9.6 ± 3.5             0.0013
  Non-Immune, n(%)                                 18(51.4)          10 (47.6)             0.79
  Two or more WHO severity criteria, n(%)          1 (0.3)           11 (52.4)             \<0.0001
  Platelets (x103/mm^3^), Mean ± SD                85.8 ± 86.3       65.3 ± 57.3           0.35
  Bilirubin (mg/dl), Mean ± SD                     4.8 ± 4.7         6.9 ± 7.2             0.08
  Creatinine (mg/dl), Mean ± SD                    3.6 ± 3.1 5       3.9 ± 2.6             0.67
  C-reactive protein (mg/l), Mean ± SD             118.0 ± 87.5      140.0 ± 103.0         0.45
  Arterial lactates (mmol/l), Mean ± SD            3.4 ± 2.89        5.4 ± 4.6             0.019
  Parasitemia (x10^3^parasites/mm^3^), Mean ± SD   30.5 ± 28.8       27.8 ± 36.7           0.73

Conclusions
===========

In this review, the criteria usually pointed as predictors of a poor outcome on sepsis cases were found to have statistical significance in malaria-related deaths.
